Yttrium 90 Radioembolization for Hepatocellular Carcinoma

Logan Howerton1

  • 1Logan Howerton, BSRS, R.T.(R)(VI) is radiologic technologist on the vascular and interventional radiology team at the University of North Carolina Hospital in Chapel Hill. She is a recent graduate of the University of North Carolina at Chapel Hill.

Radiologic Technology
|November 3, 2021
PubMed
Summary

Radioembolization delivers targeted radiation therapy for liver cancer using yttrium 90 (90Y). Careful pretreatment planning, including angiography and perfusion imaging, ensures safe and effective treatment for hepatocellular carcinoma.

Related Concept Videos